TORRISI, SEBASTIANO EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 634
EU - Europa 294
AF - Africa 84
AS - Asia 77
OC - Oceania 1
Totale 1.090
Nazione #
US - Stati Uniti d'America 628
IT - Italia 117
IE - Irlanda 99
CI - Costa d'Avorio 69
CN - Cina 41
VN - Vietnam 29
RU - Federazione Russa 18
FR - Francia 15
SN - Senegal 11
DE - Germania 10
UA - Ucraina 7
CA - Canada 6
DK - Danimarca 6
NG - Nigeria 4
AT - Austria 3
CH - Svizzera 3
SE - Svezia 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
NL - Olanda 2
PL - Polonia 2
AL - Albania 1
BD - Bangladesh 1
BE - Belgio 1
FI - Finlandia 1
GB - Regno Unito 1
GR - Grecia 1
HU - Ungheria 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SG - Singapore 1
Totale 1.090
Città #
Chandler 197
Houston 132
Dublin 99
Abidjan 69
Ashburn 35
Dong Ket 27
Cambridge 26
Andover 25
Lawrence 25
Catania 20
Des Moines 16
Nanjing 13
Wilmington 13
Dakar 11
Bremen 10
Ferentino 10
Woodbridge 8
Falls Church 7
Shenyang 6
Boardman 5
Jacksonville 5
Latina 5
Toronto 5
Abuja 4
Saint Petersburg 4
Acate 3
Ann Arbor 3
Hebei 3
Milan 3
Nanchang 3
Napoli 3
Norwalk 3
Fairfield 2
Hanoi 2
Jesi 2
Marano Di Napoli 2
Paris 2
Paterno 2
Patti 2
Pozzallo 2
Redmond 2
San Francisco 2
Viagrande 2
Auckland 1
Augusta 1
Beijing 1
Benevento 1
Brescia 1
Brussels 1
Budapest 1
Central 1
Changchun 1
Chiesina Uzzanese 1
Corato 1
Den Haag 1
Dhaka 1
Edinburgh 1
Forino 1
Fuzhou 1
Groningen 1
Jiaxing 1
Jinan 1
Kowloon 1
L'hay-les-roses 1
Lappeenranta 1
Lausanne 1
Los Angeles 1
Moscow 1
Ottawa 1
Pisa 1
Pozzo Di Gotto 1
Prague 1
Redwood City 1
Reggio Calabria 1
Rome 1
San Giovanni la Punta 1
San Jose 1
Seattle 1
Singapore 1
Taizhou 1
Tianjin 1
Tirana 1
Vienna 1
Washington 1
Totale 861
Nome #
The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study 187
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes 90
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 59
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here? 51
Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis 49
Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series 44
COMPARISON BETWEEN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES: A PROSPECTIVE COHORT 44
Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers? 44
Comorbidities of IPF: How do they impact on prognosis 43
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome 43
Cryptogenic organizing pneumonia: Evolution of morphological patterns assessed by HRCT 41
Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists 41
State of the art in interstitial pneumonia with autoimmune features: A systematic review on retrospective studies and suggestions for further advances 40
Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT 38
Improvement in the management of chronic obstructive pulmonary disease following a clinical educational program: Results from a prospective cohort study in the Sicilian general practice setting 36
Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases 36
The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features 35
When to start and when to stop antifibrotic therapies 34
HRCT patterns of drug-induced interstitial lung diseases: A review 32
Pulmonary fibrosis and lung cancer: not the same disease, but not so different 29
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases 29
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 28
Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology 28
PerFECT 2.0: A Web-Based Platform Designed to Facilitate and Support the Diagnosis of Patients with Idiopathic Pulmonary Fibrosis in Italy 21
Malnutrition in idiopathic pulmonary fibrosis: The Great Forgotten Comorbidity! 18
Evolution and treatment of idiopathic pulmonary fibrosis 16
Quantum-inspired minimum distance classification in a biomedical context 1
Totale 1.157
Categoria #
all - tutte 4.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 0 0 0 0 0 0 0 4 14
2019/2020196 42 14 28 38 31 24 5 2 0 4 3 5
2020/2021136 4 26 3 1 47 8 3 0 13 3 5 23
2021/2022185 5 32 8 9 33 5 28 6 6 3 4 46
2022/2023456 28 43 8 74 39 72 2 63 96 5 17 9
2023/2024145 13 37 10 5 4 63 1 9 0 3 0 0
Totale 1.157